Kymera Therapeutics Sets Nov. 23 Date for KT-621 Trial Results
Kymera Therapeutics says it will announce Phase 2b BROADEN2 atopic dermatitis trial results on Nov. 23, 2026.
Story updates
09:01:07 PM UTC
SquawkNews
Company to host video conference call and webcast at 8:00 a.m. ET on Monday, November 23, 2026 WATER